La investigación fue desencadenada por una notificación que alertó sobre la comercialización de una serie de productos bajo las marcas "King Hardcore," "Innovative," y "KN Nutrition," entre otros. Estos productos fueron identificados como "MK-677 Dietary Supplement," "ANAVAR Dietary Supplement," "LIGANDROL Dietary Supplement," "M-DROL Dietary Supplement," "SUPER DROL Dietary Supplement," "CARDARINE Dietary Supplement," "S-23 Dietary Supplement," "TRENAVAR Dietary Supplement," "FEMATROPE Dietary Supplement," "Hell Fire EPH 150 EPHEDRA EXTRACT," y "IBUTAMOREN MK 677 Dietary Supplement."